The Roles of Amylin in the Periphery

por Wookey, P. J., Cooper, M. E.
Publicado 2001

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

por Miao, Y., Dobre, D., Lambers Heerspink, H. J., Brenner, B. M., Cooper, M. E., Parving, H-H., Shahinfar, S., Grobbee, D., de Zeeuw, D.
Publicado 2010

Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

por Miao, Y., Dobre, D., Lambers Heerspink, H. J., Brenner, B. M., Cooper, M. E., Parving, H.-H., Shahinfar, S., Grobbee, D., de Zeeuw, D.
Publicado 2011

Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy

por Zhao, L., Zhang, Y., Liu, F., Yang, H., Zhong, Y., Wang, Y., Li, S., Su, Q., Tang, L., Bai, L., Ren, H., Zou, Y., Wang, S., Zheng, S., Xu, H., Li, L., Zhang, J., Chai, Z., Cooper, M. E., Tong, N.
Publicado 2021